Medtronic recalls Paradigm REAL-Time Revel insulin pumps (MMT-523, MMT-723) due to potential insulin over- or under-delivery when pump height changes, risking severe hypoglycemia or hyperglycemia. Affected users should contact Medtronic for guidance.
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
Medtronic is recalling Paradigm REAL-Time Revel insulin pumps (MMT-523 and MMT-723 models) because moving the pump up or down relative to the body can cause incorrect insulin delivery, which may lead to life-threatening low or high blood sugar levels.
The pumps can deliver too much or too little insulin when the device is elevated or lowered compared to the body's infusion site. This happens because changes in height affect how insulin flows through the pump, potentially causing dangerous blood sugar levels.
People with diabetes using Medtronic Paradigm REAL-Time Revel insulin pumps (MMT-523 or MMT-723 models) are affected. Those who move the pump during use are at higher risk of severe blood sugar complications.
Check for the model numbers MMT-523 or MMT-723 on the pump's label. These pumps were sold with specific serial numbers listed in the recall notice.
Look for the model number MMT-523 or MMT-723 on the pump's label to confirm if it is affected.
Reach out to Medtronic for guidance on next steps, as the recall remedy is not specified in the record.
The pump can deliver too much or too little insulin when moved up or down relative to the body, causing severe hypoglycemia or hyperglycemia.
Check the pump model and contact Medtronic for guidance, as the recall remedy is not specified in the record.
Yes, if the pump is elevated or lowered relative to the infusion site, it can cause incorrect insulin delivery, leading to life-threatening blood sugar levels.
We’ve drafted a message you can send Medtronic to request your refund or repair — edit it as you like.
Subject: Recall Z-1750-2026 — Medtronic Medtronic Hello, I own a Medtronic that is covered by recall Z-1750-2026 from Medtronic. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
